Okay.
Dr. Tunis, many Canadians have received their first dose of AstraZeneca. Many of them are now coming up for their second dose. Most provinces, if not all of them—I'm not sure—are not using the drug due to VITT concerns and supply issues. Of course, the mixing data, using AstraZeneca with messenger RNA vaccines, is apparently not conclusive to this day.
What is NACI's recommendation to Canadians who received their first dose of AstraZeneca on what they should be taking for their second dose? Should it be AstraZeneca or should it be a messenger RNA vaccine? What data is that answer based on, please?